Participant characteristics

All Patients (n = 50)LTLE (n = 40)RTLE (n = 10)HC (n = 22)P Value
Sex
 Female32 (64%)25 (62.5%)7 (70%)14 (63.6%)>.05
 Male18 (36%)15 (37.5%)3 (30%)8 (36.4%)
Seizures
 FAS7 (14%)6 (15%)1 (10%)NA
 FIAS45 (90%)36 (90%)9 (90%)NA
 FBTCS7 (14%)5 (12.5%)2 (20%)NA
 FIAS frequency per mo (mean)5.5 (SD, 6.1)6 (SD, 6.5)4 (SD, 3.4)NA
 FBTCS frequency per mo (mean)0.8 (SD, 2.0)0.35 (SD, 0.95)0.3 (SD, 1.0)NA
Age and duration (mean) (yr)
 Age at scan37 (SD, 13)37 (SD, 13)35 (SD, 13)34 (SD, 11)>.05
 Age at seizure onset14 (SD, 10)14 (SD, 10)15 (SD, 6)NA
 Epilepsy duration at scan23 (SD, 15)23 (SD, 16)20 (SD, 12)NA
Pathologya
 HS23 (46%)18 (45%)5 (50%)NA
 Cavernoma3 (6%)2 (5%)1 (10%)NA
 DNT1 (2%)0 (0%)1 (10%)NA
 Focal cortical dysplasia7 (14%)7 (17.5%)0 (0%)NA
 Gliosis2 (4%)1 (2.5%)1 (10%)NA
 Other6 (12%)6 (15%)0 (0%)NA
 No abnormality11 (22%)8 (20%)3 (30%)NA
  • Note:—FAS indicates focal aware seizures; FIAS, focal with impaired awareness seizures; FBTCS, focal to bilateral tonic-clonic seizures; DNT, dysembryoplastic neuroepithelial tumor; HS, hippocampal sclerosis; LTLE, left TLE; NA, not applicable; RTLE, right TLE. Significant (P <.05) difference compared with controls.

  • a Location of the lesions are detailed in supplementary material table S.